期刊文献+

白血病患者炎症因子、VEGF表达与易栓状态关系的研究 被引量:1

The Relation Between Thrombophilia and Inflammatory Factor,VEGF in Leukemia
暂未订购
导出
摘要 目的了解白血病患者表达炎症因子IL-6、IL-8、IL-10与VEGF的水平与意义。方法以ELISA方法观察30例正常人和47例白血病患者血清IL-6、IL-8、IL-10、VEGF水平。结果初治患者血清IL-6、IL-8、IL-10、VEGF水平均明显高于对照组(P<0.05)。部分缓解组IL-6、IL-8、IL-10、VEGF较治疗前明显降低(P<0.05),但仍高于对照组。完全缓解时渐趋正常。结论炎症因子与VEGF在白血病不同病期变化,除了肿瘤性病因所致,也与肿瘤性血管内皮损伤有关,导致肿瘤性易栓状态。这些因子可作为观察白血病患者合并高凝状态观察指标。 Objective The expression and significance of IL-6, IL-8, IL-10, VEGF in acute and chromic leukemia. Methods The serum leveles of IL-6, IL-8, IL-10, VECF in 47 patients with acute and chromic leukemia and 30 normal people were measured by ELISA method. Results Before therapy patients with acute and chromic leukemia had a higher levels of IL-6, IL-8, IL-10, VEGF compared to other groups (P 〈 0.05). After therapy of acute and chromic leukemia who were partial remission IL- 6, IL- 8, IL- 10, VECF all decreased compared to before therapy( P 〈 0.05 ) , but they still had higher levels compared to nor- mal control group. There was no evident difference about IL-6, IL-8, IL-10, VEGF between complete remission and normal control group. Conclusion The change of inflammatory factor and VEGF in different stage of acute and chromic leukemia is related with tumor etiopathogenisis and tumor thrombophilia state. These factor can be used as the indicators of leukemia patients complicating thrombophilia state.
出处 《血栓与止血学》 2008年第6期261-263,共3页 Chinese Journal of Thrombosis and Hemostasis
基金 江苏省扬州市社会发展基金项目(编号:YZ2003Z006)
关键词 白血病 炎症因子 Leukemia Inflammatory Factor
  • 相关文献

参考文献10

  • 1邵剑峰.白细胞介素-6在血液病及其它肿瘤中的研究进展[J].医学综述,1997,3(5):229-232. 被引量:7
  • 2[2]DENIZOT Y,FIX P,LIOZON E,et al.Serum interleukin-8(IL-8) and IL-6 concentrations in patients with hematologic malignances[J].Blood,1996,87:4016-4017.
  • 3[3]KERR R,STIRLING D,LUDLAM CA.Interleukin 6 and haemostasis[J].Br J Haematol,2001,115(3):3-12.
  • 4[4]VAN AKEN BE,REITSMA PH,ROSENDAAL FR.Interleukin 8 and venous thrombosis:evidence for a role of inflammation in thrombosis[J].Br J Haematol,2002,116(5):173-177.
  • 5[5]NAKANO M,FURUTANI M,SHINNO H,et al.Elevation of soluble thrombomodulin antigen levels in the serum and urine of streptozotocin-induced diabetes model rats[J].Thrombosis Research,2000,99(4):83-91.
  • 6[6]KIPSHIDZE N,KIPIANI K,KIPSHIDZE NN,et al.Therapeutic angiogenesis for patients with limb ischemia by utilization of fibrin meshwork[J].Int Angiol,2003,22(4):349-355.
  • 7[7]UCHIBA M,OKAJIMA K,SUDA T,et al.Activated protein C induces endothelial cell proliferation by mitogen-activated protein kinase activation in vitro and angiogenesis in vivo[J].Circ Res,2004,95(1):34-41.
  • 8[8]ZHANG W,CHUANG YJ,OLSON ST,et al.Antiangiogenic antithrombin down-regulates the expression of the proangiogenic heparan sulfate proteoglycan,perlecan,in endothelial cells[J].Blood.2004,103(4):1185-1191.
  • 9[9]SHEN BQ,LEE DY,ZIONCHECK TF,et al.Vascular Endothelial Growth Factor KDR Receptor Signaling Potentiates Tumor Necrosis Factor-induced Tissue Factor Expression in Endothelial Cells[J].J Biol Chem,2001,276(7):5281-5286.
  • 10[10]MAKIN AJ,CHUNG NA,LIP GY,et al.Vascular endothelial growth factor and tissue factor in patients with established peripheral artery disease:a link between angiogenesis and thrombogenesis[J].Clin Sci (Lond),2003,104(4):397-404.

二级参考文献4

共引文献6

同被引文献5

引证文献1

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部